CytoDyn Provides Update on Dose Escalating Trial with Leronlimab for HIV Monotherapy for a Potential Pivotal Trial

CytoDyn Files a Phase 2 Protocol with the FDA for Leronlimab (PRO 140) and Regorafenib as a Combination Therapy for Metastatic Colorectal Cancer

CDRH Face-to-Face Meeting

Aug 28, 2019

2019 Annual Meeting of Stockholders

Sep 12, 2019